The current valuation score of Urogen Pharma Ltd is 8.49, ranking 119 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -13.87, which is -90.28% below the recent high of -1.35 and 0.00% above the recent low of -13.87.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.